50 related articles for article (PubMed ID: 38589444)
41. RSAD2 is abundant in atherosclerotic plaques and promotes interferon-induced CXCR3-chemokines in human smooth muscle cells.
Hayderi A; Kumawat AK; Shavva VS; Dreifaldt M; Sigvant B; Petri MH; Kragsterman B; Olofsson PS; Sirsjö A; Ljungberg LU
Sci Rep; 2024 Apr; 14(1):8196. PubMed ID: 38589444
[TBL] [Abstract][Full Text] [Related]
42. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
43. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
44. CXCR3, inflammation, and autoimmune diseases.
Lacotte S; Brun S; Muller S; Dumortier H
Ann N Y Acad Sci; 2009 Sep; 1173():310-7. PubMed ID: 19758167
[TBL] [Abstract][Full Text] [Related]
45. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.
Koper OM; Kamińska J; Sawicki K; Kemona H
Adv Clin Exp Med; 2018 Jun; 27(6):849-856. PubMed ID: 29893515
[TBL] [Abstract][Full Text] [Related]
46. Crucial Roles of RSAD2/viperin in Immunomodulation, Mitochondrial Metabolism and Autoimmune Diseases.
Chen S; Ye J; Lin Y; Chen W; Huang S; Yang Q; Qian H; Gao S; Hua C
Inflammation; 2024 Jun; ():. PubMed ID: 38909344
[TBL] [Abstract][Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
